180 related articles for article (PubMed ID: 35081296)
1. Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant.
Zhao X; Li D; Ruan W; Chen Z; Zhang R; Zheng A; Qiao S; Zheng X; Zhao Y; Dai L; Han P; Gao GF
N Engl J Med; 2022 Mar; 386(9):894-896. PubMed ID: 35081296
[No Abstract] [Full Text] [Related]
2. SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.
Rössler A; Riepler L; Bante D; von Laer D; Kimpel J
N Engl J Med; 2022 Feb; 386(7):698-700. PubMed ID: 35021005
[No Abstract] [Full Text] [Related]
3. Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Bradley T; Grundberg E; Selvarangan R; LeMaster C; Fraley E; Banerjee D; Belden B; Louiselle D; Nolte N; Biswell R; Pastinen T; Myers A; Schuster J
N Engl J Med; 2021 May; 384(20):1959-1961. PubMed ID: 33755375
[No Abstract] [Full Text] [Related]
4. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.
Ai J; Zhang H; Zhang Y; Lin K; Zhang Y; Wu J; Wan Y; Huang Y; Song J; Fu Z; Wang H; Guo J; Jiang N; Fan M; Zhou Y; Zhao Y; Zhang Q; Liu Q; Lv J; Li P; Qiu C; Zhang W
Emerg Microbes Infect; 2022 Dec; 11(1):337-343. PubMed ID: 34935594
[No Abstract] [Full Text] [Related]
5. SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
Falsey AR; Frenck RW; Walsh EE; Kitchin N; Absalon J; Gurtman A; Lockhart S; Bailey R; Swanson KA; Xu X; Koury K; Kalina W; Cooper D; Zou J; Xie X; Xia H; Türeci Ö; Lagkadinou E; Tompkins KR; Shi PY; Jansen KU; Şahin U; Dormitzer PR; Gruber WC
N Engl J Med; 2021 Oct; 385(17):1627-1629. PubMed ID: 34525276
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
[No Abstract] [Full Text] [Related]
7. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
Wu S; Huang J; Zhang Z; Wu J; Zhang J; Hu H; Zhu T; Zhang J; Luo L; Fan P; Wang B; Chen C; Chen Y; Song X; Wang Y; Si W; Sun T; Wang X; Hou L; Chen W
Lancet Infect Dis; 2021 Dec; 21(12):1654-1664. PubMed ID: 34324836
[TBL] [Abstract][Full Text] [Related]
8. Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645
[No Abstract] [Full Text] [Related]
9. Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
Edara VV; Hudson WH; Xie X; Ahmed R; Suthar MS
JAMA; 2021 May; 325(18):1896-1898. PubMed ID: 33739374
[TBL] [Abstract][Full Text] [Related]
10. Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
Hall VG; Ferreira VH; Ku T; Ierullo M; Majchrzak-Kita B; Chaparro C; Selzner N; Schiff J; McDonald M; Tomlinson G; Kulasingam V; Kumar D; Humar A
N Engl J Med; 2021 Sep; 385(13):1244-1246. PubMed ID: 34379917
[No Abstract] [Full Text] [Related]
11. Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies.
Wang X; Zhao X; Song J; Wu J; Zhu Y; Li M; Cui Y; Chen Y; Yang L; Liu J; Zhu H; Jiang S; Wang P
Emerg Microbes Infect; 2022 Dec; 11(1):477-481. PubMed ID: 35034583
[TBL] [Abstract][Full Text] [Related]
12. A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response: Erratum.
Transplantation; 2024 May; 108(5):e78. PubMed ID: 38659119
[No Abstract] [Full Text] [Related]
13. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
[No Abstract] [Full Text] [Related]
14. Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
Bates TA; McBride SK; Winders B; Schoen D; Trautmann L; Curlin ME; Tafesse FG
JAMA; 2022 Jan; 327(2):179-181. PubMed ID: 34914825
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.
Keskin AU; Bolukcu S; Ciragil P; Topkaya AE
J Med Virol; 2022 Jan; 94(1):39-41. PubMed ID: 34536028
[No Abstract] [Full Text] [Related]
16. Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
Sablerolles RSG; Rietdijk WJR; Goorhuis A; Postma DF; Visser LG; Geers D; Schmitz KS; Garcia Garrido HM; Koopmans MPG; Dalm VASH; Kootstra NA; Huckriede ALW; Lafeber M; van Baarle D; GeurtsvanKessel CH; de Vries RD; van der Kuy PHM;
N Engl J Med; 2022 Mar; 386(10):951-963. PubMed ID: 35045226
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study.
Yalçın TY; Topçu DI; Doğan Ö; Aydın S; Sarı N; Erol Ç; Kuloğlu ZE; Azap ÖK; Can F; Arslan H
J Med Virol; 2022 Jan; 94(1):279-286. PubMed ID: 34468990
[TBL] [Abstract][Full Text] [Related]
18. Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
Saadat S; Rikhtegaran Tehrani Z; Logue J; Newman M; Frieman MB; Harris AD; Sajadi MM
JAMA; 2021 Apr; 325(14):1467-1469. PubMed ID: 33646292
[TBL] [Abstract][Full Text] [Related]
19. A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.
Yue L; Xie T; Yang T; Zhou J; Chen H; Zhu H; Li H; Xiang H; Wang J; Yang H; Zhao H; Wei X; Zhang Y; Xie Z
J Med Virol; 2022 Jan; 94(1):35-38. PubMed ID: 34516026
[No Abstract] [Full Text] [Related]
20. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
Liu Y; Liu J; Xia H; Zhang X; Zou J; Fontes-Garfias CR; Weaver SC; Swanson KA; Cai H; Sarkar R; Chen W; Cutler M; Cooper D; Muik A; Sahin U; Jansen KU; Xie X; Dormitzer PR; Shi PY
N Engl J Med; 2021 Jul; 385(5):472-474. PubMed ID: 33979486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
